Drug Shortage Report for MYLAN-BUDESONIDE AQ
| Report ID | 23169 |
| Drug Identification Number | 02241003 |
| Brand name | MYLAN-BUDESONIDE AQ |
| Common or Proper name | BUDESONIDE AQ |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 64MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL |
| Packaging size | 120 |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2018-10-30 |
| Actual start date | 2018-11-05 |
| Estimated end date | 2020-03-03 |
| Actual end date | 2020-03-03 |
| Shortage status | Resolved |
| Updated date | 2020-03-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v35 | 2017-12-13 | English | Compare |
| v34 | 2017-12-13 | English | Compare |
| v33 | 2017-12-11 | French | Compare |
| v32 | 2017-12-11 | English | Compare |
| v31 | 2017-12-08 | French | Compare |
| v30 | 2017-12-08 | English | Compare |
| v29 | 2017-12-06 | French | Compare |
| v28 | 2017-12-06 | English | Compare |
| v27 | 2017-12-01 | French | Compare |
| v26 | 2017-12-01 | English | Compare |
| v25 | 2017-11-30 | French | Compare |
| v24 | 2017-11-30 | English | Compare |
| v23 | 2017-11-29 | French | Compare |
| v22 | 2017-11-29 | English | Compare |
| v21 | 2017-11-24 | French | Compare |
| v20 | 2017-11-24 | English | Compare |
| v19 | 2017-11-23 | French | Compare |
| v18 | 2017-11-23 | English | Compare |
| v17 | 2017-11-22 | French | Compare |
| v16 | 2017-11-22 | English | Compare |